一类Scavenger受体MARCO负面调节ACE表达和阿尔多素的生产
Conan J O O'Brien1, Giorgio Ratti1, Hellen Veida-Silva2,1
1Department of Physiology, Anatomy, & Genetics, University of Oxford, United Kingdom.
bioRxiv : the preprint server for biology
|March 17, 2025
概括
膜巨细胞通过MARCO受体,降低雄性小鼠的阿尔多素生产和血管素转化酶 (ACE) 表达,揭示了免疫系统参与血压调节的作用.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 心血管生理学心血管生理学
背景情况:
- 阿尔多是一个关键的类固醇激素,调节血压和体积.
- 氨酸- ангиотензин阿尔多素系统 (RAAS) 主要控制阿尔多素的释放.
- RAAS涉及上腺,脏和肺部之间的相互作用.
研究的目的:
- 为了研究拾尸体受体MARCO在阿尔多素调节中的作用.
- 探索膜巨细胞在RAAS中的潜在参与.
- 为了确定免疫和内分泌系统之间的新型相互作用.
主要方法:
- 使用了雄性小鼠模型.
- 研究了血管酶转化酶 (Ace) 的表达.
- 评估与MARCO表达相关的阿尔多素产量.
主要成果:
- 研究人员发现,MARCO在膜巨细胞上表达,对阿尔多素的产生产生产生负面调节.
- 马可表达抑制了肺中的血管酶转化酶 (Ace) 表达.
- 膜巨细胞在调节RAAS组件方面发挥着作用.
结论:
- 气膜巨被确定为氨酸-氨酸-阿尔多素系统的新参与者.
- 证明了免疫和内分泌系统之间的新型相互作用.
- 马可受体信号影响血压调节通路.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
439
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
439
Antihypertensive Drugs: Angiotensin II Receptor Blockers
564
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
564
Antihypertensive Drugs: Direct Renin Inhibitors
466
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
466
Antihypertensive Drugs: Action of β1 Blockers
295
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
295
Adrenergic Receptors: ɑ Subtype
1.4K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.4K


